Real-world effectiveness and safety of omalizumab in patients with uncontrolled severe allergic asthma from the Czech Republic

by Olga Růžičková Kirchnerová, Tomáš Valena, Jakub Novosad, Milan Teřl
Published 2018-06-01

Effect of individual allergen sensitization on omalizumab treatment outcomes in patients with severe allergic asthma determined using data from the Czech Anti-IgE Registry

by Petr Vaník, Jakub Novosad, Olga Kirchnerová, Irena Krčmová, Milan Teřl, Czech Anti-IgE Registry collaborators
Published 2020-09-01

Serum periostin levels in asthma patients in relation to omalizumab therapy and presence of chronic rhinosinusitis with nasal polyps

by Jakub Novosad, Irena Krčmová, Vladimír Bartoš, Marcela Drahošová, Petr Vaník, Olga Růžičková-Kirchnerová, Milan Teřl, Jan Krejsek
Published 2020-05-01